Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Navigating governance: Balancing authentic leadership, ethical responsibility, and algorithmic risk

11/06/2026 Published by Pharma Biz

In contemporary organizational development, the discourse surrounding "authentic leadership" heavily emphasizes its utility in fostering organizational trust and psychological safety.... Read more

Tags: #Human Resources

When infinite productivity breaks the brain: Identifying and overcoming “AI Cognitive Exhaustion”

11/06/2026 Published by Pharma Biz

The reality: The dark side of artificial efficiency metrics The exponential growth of advanced multi-agent systems and automated workflows is... Read more

Category: Uncategorized

Tags: #Capability Development

DKSH enters strategic distribution compact with BridgeBio for rare cardiac therapy in selected Asia Pacific markets

11/06/2026 Published by Pharma Biz

DKSH has officially entered into a definitive strategic distribution and commercialization partnership with BridgeBio, a U.S. biotechnology innovator focused on... Read more

Category: Uncategorized

Tags: #Global Trends

NICE clears AbbVie’s migraine drug Aquipta for acute NHS reimbursement in England and Wales

11/06/2026 Published by Pharma Biz

The National Institute for Health and Care Excellence (NICE) has published final draft guidance enabling AbbVie’s Aquipta (atogepant) to be... Read more

Category: Uncategorized

Tags: #Global Trends

European Medicines Agency validates Bayer’s asundexian application — First Factor XIa inhibitor enters regulatory assessment for stroke prevention

11/06/2026 Published by Pharma Biz

German life science enterprise Bayer has officially announced that the European Medicines Agency (EMA) has validated and initiated its centralized... Read more

Category: Uncategorized

Tags: #Global Trends

Parabilis Medicines sets historic biotech record with $670 million US IPO

11/06/2026 Published by Pharma Biz

U.S. biotechnology innovator Parabilis Medicines has successfully secured the largest initial public offering (IPO) in global biotech history. The landmark... Read more

Category: Uncategorized

Tags: #Global Trends

FDA clears expanded indications for Organon’s Tofidence to treat cytokine release syndrome and COVID-19

11/06/2026 Published by Pharma Biz

Organon has officially announced that the U.S. Food and Drug Administration (FDA) has approved the expanded clinical utilization of its... Read more

Category: Uncategorized

Tags: #Global Trends

Pfizer CEO warns German investments are at risk over domestic drug pricing policies

11/06/2026 Published by Pharma Biz

U.S. pharmaceutical titan Pfizer is officially reviewing the timeline and physical scope of its planned investments within Germany. The corporate... Read more

Category: Uncategorized

Tags: #Global Trends